This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Celanese to Increase Prices of Acetyl Intermediates in China
by Zacks Equity Research
Celanese's (CE) latest hike is incremental to earlier announced price increases.
Eastman Chemical (EMN) Poised on Cost Actions & Innovations
by Zacks Equity Research
Eastman Chemical (EMN) should gain from its cost management actions and growth in high-margin innovation products amid a challenging environment.
Here's Why You Should Hold Onto Celanese (CE) Stock Now
by Zacks Equity Research
Celanese's (CE) strategic measures including cost savings through productivity actions and acquisitions are expected to drive its earnings.
Celanese (CE) Set to Increase Prices of Acetyls Products
by Zacks Equity Research
Celanese (CE) is undertaking price-increase initiatives in the wake of raw material cost inflation.
Celanese (CE) Down 10.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Celanese (CE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Celanese (CE) Wraps Up Offering of Senior Unsecured Notes
by Zacks Equity Research
The deal extends Celanese's (CE) debt maturity profile and reduces interest expenses.
What's in the Offing for VALE (VALE) This Earnings Season?
by Zacks Equity Research
Though the Brumadinho dam rupture has impacted VALE's (VALE) production in the first quarter of 2019, results are likely to benefit from higher iron ore prices.
Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Cadence Design System, CSX, Celanese and Zoetis
Celanese's (CE) Q1 Earnings Top Estimates, Revenues Trail
by Zacks Equity Research
Lower volumes and prices hurt Celanese's (CE) revenues in the first quarter. The company reaffirms its earnings guidance for 2019.
4 GARP Stocks to Scoop Up for Maximum Returns
by Zacks Equity Research
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
Celanese (CE) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not show that Celanese (CE) is likely to beat estimates this quarter.
3 Chemical Stocks Worth Betting on Before Their Q1 Earnings
by Anindya Barman
We have shortlisted three chemical stocks that are worth investing before the Q1 earnings season hits full throttle.
Earnings Preview: Celanese (CE) Q1 Earnings Expected to Decline
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CE vs. NGVT: Which Stock Is the Better Value Option?
by Zacks Equity Research
CE vs. NGVT: Which Stock Is the Better Value Option?
Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese (CE) to Increase Prices of Acetyl Intermediates
by Zacks Equity Research
Celanese (CE) is undertaking price-hike initiatives to offset raw material cost inflation.
Celanese (CE) to Hike Prices of Ateva EVA Polymers in Asia
by Zacks Equity Research
Celanese (CE) undertakes price-hike initiative to offset the negative impact of raw material cost inflation.
Celanese Boosts TPC Production to Support Customer Growth
by Zacks Equity Research
Celanese's (CE) move supports the consistent growth in the global engineered materials business.
New Strong Sell Stocks for February 11th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Celanese's (CE) Earnings and Sales Trail Estimates in Q4
by Zacks Equity Research
Celanese's (CE) 2018 results gain from strong contributions from the Acetyl Chain and Engineered Materials. The company projects adjusted EPS of roughly $10.50 for 2019.
Celanese (CE) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of -1.65% and -2.39%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Celanese (CE) to Report Q4 Earnings: What's in the Offing?
by Anindya Barman
Celanese's (CE) productivity initiatives and price increase actions are likely to lend support to earnings in Q4.
Celanese (CE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Celanese Inks Deal With Linde to Buy Syngas Production Unit
by Zacks Equity Research
The syngas unit acquisition opens up productivity and growth opportunities for Celanese (CE).
3 Chemical Stocks to Enrich Your Portfolio Before Q4 Earnings
by Anindya Barman
We have shortlisted three chemical stocks that are worth investing in before the Q4 earnings season hits full throttle.